FMP
Sera Prognostics, Inc.
SERA
NASDAQ
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
10.34 USD
0.3 (2.9%)
About
ceo
Ms. Evguenia Lindgardt M.B.A.
sector
Healthcare
industry
Medical - Diagnostics & Research
website
https://seraprognostics.com
exchange
NASDAQ
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
CIK
0001534969
ISIN
US81749D1072
CUSIP
81749D107
Address
2749 East Parleys Way
Phone
801 990 0520
Country
US
Employee
55
IPO Date
Jul 15, 2021
Summary
CIK
0001534969
Exchange
NASDAQ
Industry
Medical - Diagnostic...
Sector
Healthcare
CUSIP
81749D107
ISIN
US81749D1072
Country
US
Price
10.34
Beta
1.49
Volume Avg.
226.03k
Market Cap
325.27M
Shares
-
52-Week
1.52-11.32
DCF
-0.9
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-8.91
P/B
-
Website
https://seraprognostics.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest SERA News
It looks like there's no news available.
